Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Notes Payables: 2015-2021

Historic Notes Payables for Nutex Health (NUTX) over the last 7 years, with FY2021 value amounting to $877172.0.

  • Nutex Health's Notes Payables fell 6716.5% to $553150.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $553150.0, marking a year-over-year decrease of 6716.5%. This contributed to the annual value of $877172.0 for FY2021, which is 8949.9% up from last year.
  • As of FY2021, Nutex Health's Notes Payables stood at $877172.0, which was up 8949.9% from $462890.0 recorded in FY2020.
  • In the past 5 years, Nutex Health's Notes Payables registered a high of $2.1 million during FY2019, and its lowest value of $52500.0 during FY2017.
  • In the last 5 years, Nutex Health's Notes Payables had a median value of $779779.0 in 2018 and averaged $856880.2.
  • In the last 5 years, Nutex Health's Notes Payables plummeted by 9831.68% in 2017 and then surged by 138529.33% in 2018.
  • Over the past 5 years, Nutex Health's Notes Payables (Annual) stood at $52500.0 in 2017, then soared by 1385.29% to $779779.0 in 2018, then soared by 170.85% to $2.1 million in 2019, then crashed by 78.08% to $462890.0 in 2020, then soared by 89.5% to $877172.0 in 2021.
  • Its Notes Payables stands at $877172.0 for FY2021, versus $462890.0 for FY2020 and $2.1 million for FY2019.